Renaissance Technologies
OM icon

Renaissance Technologies’s Outset Medical OM Stock Holding History

Renaissance Technologies’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$188K Sell
43,428
-178,647
-80% -$781K ﹤0.01% 2893
2026
Q1 		$853K Buy
222,075
+176,870
+391% +$725K ﹤0.01% 2346
2025
Q4 		$168K Buy
45,205
+4,745
+12% +$40.7K ﹤0.01% 2914
2025
Q3 		$571K Buy
40,460
+16,600
+70% +$259K ﹤0.01% 2734
2025
Q2 		$458K Sell
23,860
-17,346
-42% -$271K ﹤0.01% 2879
2025
Q1 		$456K Sell
41,206
-4,577
-10% -$54.6K ﹤0.01% 2782
2024
Q4 		$762K Buy
45,783
+42,171
+1,168% +$526K ﹤0.01% 2631
2024
Q3 		$36.7K Buy
+3,612
New +$107K ﹤0.01% 3379
2024
Q2 		– Sell
-30,159
Closed -$1M – 3833
2024
Q1 		$1M Buy
30,159
+7,999
+36% +$405K ﹤0.01% 2480
2023
Q4 		$1.8M Buy
22,160
+14,227
+179% +$1.16M ﹤0.01% 2018
2023
Q3 		$1.29M Buy
+7,933
New +$1.87M ﹤0.01% 2126
2023
Q2 		– Sell
-9,640
Closed -$2.66M – 4172
2023
Q1 		$2.66M Buy
9,640
+7,507
+352% +$2.76M ﹤0.01% 1851
2022
Q4 		$826K Sell
2,133
-1,194
-36% -$337K ﹤0.01% 2647
2022
Q3 		$795K Buy
+3,327
New +$891K ﹤0.01% 2635
2022
Q2 		– Sell
-3,427
Closed -$2.33M – 4468
2022
Q1 		$2.33M Sell
3,427
-10,566
-76% -$6.36M ﹤0.01% 2126
2021
Q4 		$9.67M Buy
+13,993
New +$10.3M 0.01% 1091

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Renaissance Technologies's OM Position: Q2 2026 in Review

Renaissance Technologies reduced its Outset Medical (OM) stake by 80% in Q2 2026, selling an estimated $781K and leaving 43,428 shares worth $188K. The position accounts for ﹤0.01% of the portfolio, ranked #2893.

Renaissance Technologies first reported a position in OM in Q4 2021 and has held it in 16 quarters since. The position peaked at $9.67M in Q4 2021. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • Renaissance Technologies held 43,428 shares of Outset Medical worth $188K as of Q2 2026.
  • Renaissance Technologies sold 178,647 Outset Medical shares in Q2 2026, an estimated $781K.
  • Outset Medical made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2893 holding.
  • Renaissance Technologies first reported a position in Outset Medical in Q4 2021 and has held it in 16 quarters since.
  • Renaissance Technologies's Outset Medical position peaked at $9.67M in Q4 2021.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.